Get the Stockscreener App
4.78
2.58%
0.12
After Hours:
4.78
Cytek Biosciences Inc stock is traded at $4.78, with a volume of 793.36K.
It is up +2.58% in the last 24 hours and up +5.52% over the past month.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.
See More
Previous Close:
$4.66
Open:
$4.73
24h Volume:
793.36K
Relative Volume:
1.08
Market Cap:
$617.30M
Revenue:
$201.49M
Net Income/Loss:
$-66.54M
P/E Ratio:
-9.1976
EPS:
-0.5197
Net Cash Flow:
$-8.88M
1W Performance:
+4.60%
1M Performance:
+5.52%
6M Performance:
+19.20%
1Y Performance:
+25.79%
1-Day Range:
$4.73
$4.97
1-Week Range:
$4.355
$4.97
52-Week Range:
$2.37
$6.18
Cytek Biosciences Inc Stock (CTKB) Company Profile
Name
Cytek Biosciences Inc
Sector
Industry
Phone
(877) 922-9835
Address
47215 LAKEVIEW BOULEVARD, FREMONT
Compare CTKB vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
4.78 | 601.80M | 201.49M | -66.54M | -8.88M | -0.5197 |
ABT
Abbott Laboratories
|
87.17 | 152.48B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 111.40B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 100.53B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 84.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 48.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-25 | Resumed | Morgan Stanley | Equal-Weight |
| May-09-25 | Downgrade | TD Cowen | Buy → Hold |
| Jan-31-25 | Downgrade | Goldman | Buy → Sell |
| Dec-14-23 | Initiated | Stephens | Overweight |
| Jul-19-23 | Initiated | Raymond James | Mkt Perform |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
View All
Cytek Biosciences Inc Stock (CTKB) Latest News
New Cytek Biosciences kit aims to boost high-resolution T cell analysis - Traders Union
Cytek Biosciences (NASDAQ: CTKB) details 2026 votes on board, pay and auditor - Stock Titan
CTKB Technical Analysis | Trend, Signals & Chart Patterns | CYTEK BIOSCIENCES INC (NASDAQ:CTKB) - ChartMill
Cytek Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026 - 富途牛牛
Attachment - GlobeNewswire
Cytek Biosciences, Inc. (CTKB) Reports Q3 Loss, Tops Revenue Estimates - MSN
Cytek Biosciences outlines $205M–$212M 2026 revenue target amid record Q4 and growth in recurring revenue - MSN
Cytek Biosciences sets May 7 webcast for Q1 2026 results - Stock Titan
Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Cytek Biosciences unveils AI-driven single-cell imaging webinar on stem cell heterogeneity - Traders Union
Is Cytek (CTKB) stock underpriced in the market (-1.08%) 2026-04-20Elite Trading Signals - Cổng thông tin điện tử Tỉnh Sơn La
Attendees at ImmunologyAAI 109th meeting explore Cytek Biosciences new technology offerings - Traders Union
Cytek Biosciences, Inc. (CTKB) Stock Analysis: Unveiling a 27.93% Potential Upside for Investors - DirectorsTalk Interviews
249,812 Shares in Cytek Biosciences, Inc. $CTKB Purchased by Tudor Investment Corp ET AL - MarketBeat
Cytek Biosciences (CTKB) Inspiring Confidence With Aurora CS System Updates - Yahoo Finance
Cytek Biosciences unveils 21-color T-cell kit to boost immunoprofiling workflows - Traders Union
Aug Action: Can Cytek Biosciences Inc sustain its profitabilityMarket Growth Summary & Weekly Watchlist of Top Performers - baoquankhu1.vn
Millennium Group reports 6.64M shares in Cytek Biosciences (CTKB) - Stock Titan
Cytek Biosciences streamlines drop charge optimization for small sample workflows - Traders Union
Stock Market Recap: Is Cytek Biosciences Inc stock showing strong momentumTrade Performance Summary & Fast Entry High Yield Stock Tips - baoquankhu1.vn
How does currency impact Cytek (CTKB) Stock | Price at $4.59, Down 0.22%Viral Momentum Stocks - Newser
Is Cytek (CTKB) Stock Near Support | Price at $4.58, Up 1.10%Elite Trading Signals - Newser
Cytek Biosciences, Inc. (8EQ.F) stock price, news, quote and history - Yahoo Finance UK
Tudor Investment Corp ET AL Invests $867,000 in Cytek Biosciences, Inc. $CTKB - MarketBeat
Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives $5.38 Consensus PT from Analysts - Defense World
Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Vanguard realignment leaves Cytek (NASDAQ: CTKB) ownership at 0 after amendment - Stock Titan
Nautilus Biotechnology And 2 Other Compelling Penny Stocks For Your Watchlist - sahmcapital.com
EPS Watch: What is the Moat Score of Cytek Biosciences Inc2026 Rallies & Smart Allocation Stock Reports - baoquankhu1.vn
Tranche Update on Cytek Biosciences, Inc.'s Equity Buyback Plan announced on December 30, 2024. - marketscreener.com
CTKB Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Cytek Biosciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Topline Capital Management LLC Has $24.10 Million Position in Cytek Biosciences, Inc. $CTKB - MarketBeat
US Stocks Recap: How does Cytek Biosciences Inc compare to its peersMarket Growth Report & Real-Time Market Sentiment Reports - baoquankhu1.vn
Cytek Biosciences (CTKB) director converts 6,107 RSUs into common stock - Stock Titan
Cytek Biosciences (CTKB) CLO receives new options, 226,453 RSUs and stock from vesting - Stock Titan
Cytek Biosciences (NASDAQ: CTKB) SVP granted options, RSUs and sees RSU vesting - Stock Titan
Cytek Biosciences (CTKB) CEO awarded options, RSUs and surrenders shares for taxes - Stock Titan
Cytek Biosciences (CTKB) CFO receives new equity awards and RSU vesting - Stock Titan
Cytek Biosciences (CTKB) CTO granted stock options and 227,535 RSUs - Stock Titan
Cytek Biosciences (NASDAQ: CTKB) director gains 2,908 shares via RSU vesting - Stock Titan
Latest CTKB NewsAmberstone Biosciences Secures $12 Million ... - Stock Titan
Cytek Biosciences, Inc. (CTKB) Stock Analysis: Unveiling a 44% Potential Upside in the Medical Devices Space - DirectorsTalk Interviews
Sell Signal: What is the Moat Score of Cytek Biosciences IncTrade Performance Summary & AI Driven Stock Price Forecasts - baoquankhu1.vn
Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact - Taiwan News
Cytek Biosciences expands global reach with one year of Singapore operations - Traders Union
Cytek Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact - Bitget
Cytek Biosciences Highlights Aurora Evo, Recurring Revenue Growth and 2026 Outlook at TD Cowen Conference - Yahoo Finance
How The Cytek Biosciences (CTKB) Story Is Shifting With New Targets And 2026 Guidance - Yahoo Finance
Cytek Biosciences Balances Growth With Margin Strain - The Globe and Mail
Cytek Biosciences Inc Stock (CTKB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):